Pfizer Parkinson's UK AstraZeneca Digestive Cancers Europe Bayer Bristol Myers Squibb Ovacome Novo Nordisk Anthony Nolan AbbVie NHS Jazz Pharmaceuticals MSD Lung Cancer Europe Astellas Macmillan Cancer Support Daiichi Sankyo Menopause Alliance Beds and Luton CSL Behring GAfPA Kyowa Kirin Mundipharma Pfizer Parkinson's UK AstraZeneca Digestive Cancers Europe Bayer Bristol Myers Squibb Ovacome Novo Nordisk Anthony Nolan AbbVie NHS Jazz Pharmaceuticals MSD Lung Cancer Europe Astellas Macmillan Cancer Support Daiichi Sankyo Menopause Alliance Beds and Luton CSL Behring GAfPA Kyowa Kirin Mundipharma

08.15 Registration & Informal Networking

OPENING REMARKS

09.00 GIC Welcome & Morning Chair’s Opening Remarks

Anthony Cuncliffe, National Lead Medical Adviser, Macmillan Cancer Support

Overcoming Barriers To Patient Centricity

09.10 Put Your Patients At The Core & Break Through Barriers By Streamlining Pathways & Elevating Early Patient Involvement To Truly Drive Patient-Centric Decision-Making

  • Prioritise meaningful, patient-centred conversations to overcome heavy workloads, time pressures and short appointments that limit opportunities for shared decision-making
  • How can we untangle the “dizzying maze” of pharma and healthcare systems; hospitals, clinics, and pharmacies so patients aren’t met with mixed messages or repeated steps along the way?
  • Late-stage involvement leaves patients feeling unheard! Embed patient voices into trial design, endpoint selection and communication planning right from the start

Soraya Clarke, Strategic Participation Manager, Macmillan Cancer Support

Patient Involvement In HTA

PANEL Q&A

09.30 Overcome HTA Obstacles With Earlier Patient Input, Stronger Real-World Evidence & Collaborative Approaches That Elevate What Truly Matters To Patients In 2026 & Beyond

  • How can pharma ensure patient voices genuinely influence HTA frameworks, evidence requirements and value assessments, and not just appear as an add-on?
  • As HTA bodies demand more patient-centred evidence, unpack how pharma can partner with patients earlier to strengthen dossiers and reflect what truly matters to those needing the support
  • Analyse the barriers to effective patient input in HTA to explore how to overcome hurdles and learn from impactful case studies where patient voices have driven change across Europe

Jose Diaz, Global HEOR, Health Systems Economics & Value of Innovation, Bristol Myers Squibb

FREE DOWNLOAD

Get The Full Agenda + Save £100

Work Email

At Global Insight Conferences, we have exciting offers and news about our upcoming events and industry updates that we hope you'd like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details of our privacy policy here. You can stop receiving our updates at any time.
Please remember to check your junk folder for the brochure and add @gicconferences.com to your safe senders list.

Don't Miss Out!

Book Before Thursday & Save £170!